Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition

Autor: Paolo A. Ascierto, Serigne Lo, Carlo Tondini, Richard D. Carvajal, Karijn P M Suijkerbuijk, Kerry L. Reynolds, Jessica S.W. Borgers, Jeremy Lupu, Christian U. Blank, Séverine Roy, Christian Posch, Michael Erdmann, Mario Mandalà, Ines Pires da Silva, Matteo S. Carlino, Maria Grazia Vitale, Tim Cooksley, F. Stephen Hodi, Megan H. Trager, Carola Berking, Leyre Zubiri, Laura Pala, Sharon Nahm, Dirk Schadendorf, Paola Queirolo, Alon Vaisman, Neha Papneja, Paul Lorigan, Joanna Mangana, Aljosja Rogiers, Alexander M. Menzies, Thiago Pimentel Muniz, Caroline Robert, Ryan J. Sullivan, John B. A. G. Haanen, Marcus O. Butler, Reinhard Dummer, Peter Bowling, Wilson H. Miller, Osama E. Rahma, Arielle Elkrief, Samuel D. Saibil, Chiara Tentori, Joseph M. Grimes, Michael Manos, Lisa Zimmer, Georgina V. Long, April A.N. Rose, Axel Hauschild

Publikováno v: Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer
Rogiers, A, Da Silva, I P, Tentori, C, Tondini, C A, Grimes, J M, Trager, M H, Nahm, S, Zubiri, L, Manos, M, Bowling, P, Elkrief, A, Papneja, N, Vitale, M G, Rose, A A N, Borgers, J S W, Roy, S, Mangana, J, Pimentel Muniz, T, Cooksley, T, Lupu, J, Vaisman, A, Saibil, S D, Butler, M O, Menzies, A M, Carlino, M S, Erdmann, M, Berking, C, Zimmer, L, Schadendorf, D, Pala, L, Queirolo, P, Posch, C, Hauschild, A, Dummer, R, Haanen, J, Blank, C U, Robert, C, Sullivan, R J, Ascierto, P A, Miller, W H, Stephen Hodi, F, Suijkerbuijk, K P M, Reynolds, K L, Rahma, O E, Lorigan, P C, Carvajal, R D, Lo, S, Mandala, M & Long, G V 2021, ' Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition ', Journal for ImmunoTherapy of Cancer, vol. 9, no. 1, e001931 . https://doi.org/10.1136/jitc-2020-001931
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 1 (2021)

BackgroundPatients with cancer who are infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are more likely to develop severe illness and die compared with those without cancer. The impact of immune checkpoint inhibition (ICI) o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08a1cc9e235765fb1d6543b99dc04cb3
http://europepmc.org/articles/PMC7817383

Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and The ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clinical Practice

Autor: Edoardo G. Giannini, Andrea Aglitti, Mauro Borzio, Martina Gambato, Maria Guarino, Massimo Iavarone, Quirino Lai, Giovanni Battista Levi Sandri, Fabio Melandro, Filomena Morisco, Francesca Romana Ponziani, Maria Rendina, Francesco Paolo Russo, Rodolfo Sacco, Mauro Viganò, Alessandro Vitale, Franco Trevisani, on behalf of the Associazione Italiana per lo Studio del Fegato (AISF) HCC Special Interest Group

Publikováno v: Cancers, Vol 11, Iss 11, p 1689 (2019)
Cancers

Despite progress in our understanding of the biology of hepatocellular carcinoma (HCC), this tumour remains difficult-to-cure for several reasons, starting from the particular disease environment where it arises—advanced chronic liver disease—to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fc7b2e0dd99b8333b4e79f88ccadf75
http://hdl.handle.net/11588/767977

Advances in systemic treatment of melanoma

Autor: Alexander M.M. Eggermont

Publikováno v: Annals of Oncology, 21, 339-344. Elsevier Ltd.

After decades of phase III trials failing to demonstrate an impact on survival of various drugs in metastatic melanoma there are finally significant advances in systemic therapies for melanoma emerging. Novel ways to modulate the immune system by mon

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47e7ebdd5ed421daf725bb4196f81aa1
https://doi.org/10.1093/annonc/mdq364

Highlights from the perspectives in melanoma XII conference

Autor: John M. Kirkwood, Alexander M.M. Eggermont

Publikováno v: Pigment Cell & Melanoma Research, 22(2), 156-165. Wiley-Blackwell Publishing Ltd

The following meeting highlights are from the Perspectives in Melanoma XII conference, held in Scheveningen/The Hague, the Netherlands, on October 2-4, 2008. Selected reviews are included but further discussions of these and other presentations are p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8156efc282a813b37aba8e8d120c0305
https://doi.org/10.1111/j.1755-148X.2009.00555.x

Definition of an Immunologic Response Using the Major Histocompatibility Complex Tetramer and Enzyme-Linked Immunospot Assays

Autor: Jesus Gomez-Navarro, Elisabeth Seja, Brigitte Englahner, Roberto Renteria, Maribel Ontiveros, Begoña Comin-Anduix, John A. Glaspy, James S. Economou, Deborah L. Reardon, Antoni Ribas, Antonio Gualberto

Publikováno v: Clinical Cancer Research. 12:107-116

Purpose: Define an immunologic response using the tetramer and enzyme-linked immunospot (ELISPOT) assays. Experimental Design: Ten healthy subjects and 21 patients with melanoma (all HLA-A*0201) donated a total of 121 blood samples to determine the l

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::577e9795559c294089db5f5f3fac6859
https://doi.org/10.1158/1078-0432.ccr-05-0136